Karyopharm Therapeutics Inc (KPTI) — Defensive Interval Ratio
Karyopharm Therapeutics Inc (KPTI) has a Defensive Interval Ratio of 116 days as of December 2025. Defensive assets of $29.38 Million (cash $-, short-term investments $3.20 Million, receivables $26.18 Million) cover 116 days of daily cash needs of $252.22K/day. Check how tangible is Karyopharm Therapeutics Inc's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Karyopharm Therapeutics Inc Defensive Interval Ratio (2013–2025)
This chart shows how Karyopharm Therapeutics Inc's Defensive Interval Ratio has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the ratio stands at 116 days, meaning defensive assets of $29.38 Million can fund 116 days of operations without new revenue. Also explore net asset momentum of Karyopharm Therapeutics Inc to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Karyopharm Therapeutics Inc (2013–2025)
The table below presents the year-by-year Defensive Interval Ratio for Karyopharm Therapeutics Inc from 2013 to 2025, covering 13 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Karyopharm Therapeutics Inc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 116 days | $29.38 Million | $252.22K/day | $- | $3.20 Million | ▼ -188 days |
| 2024 | 305 days | $77.00 Million | $252.78K/day | $- | $46.24 Million | ▼ -568 days |
| 2023 | 873 days | $166.17 Million | $190.35K/day | $- | $139.21 Million | ▼ -179 days |
| 2022 | 1051 days | $189.87 Million | $180.57K/day | $- | $142.78 Million | ▲ +751 days |
| 2021 | 300 days | $60.65 Million | $201.97K/day | $- | $38.16 Million | ▼ -216245 days |
| 2020 | 216546 days | $176.20 Million | $813.70/day | $- | $163.32 Million | ▲ +215436 days |
| 2019 | 1110 days | $140.96 Million | $126.99K/day | $- | $133.10 Million | ▼ -526 days |
| 2018 | 1636 days | $210.18 Million | $128.50K/day | $- | $210.18 Million | ▲ +1064 days |
| 2017 | 572 days | $77.47 Million | $135.53K/day | $- | $77.47 Million | ▼ -1198 days |
| 2016 | 1770 days | $79.89 Million | $45.14K/day | $- | $79.89 Million | ▼ -1059 days |
| 2015 | 2829 days | $117.28 Million | $41.46K/day | $- | $117.28 Million | ▲ +1193 days |
| 2014 | 1635 days | $55.12 Million | $33.70K/day | $- | $55.12 Million | ▲ +1635 days |
| 2013 | 0 days | $0.00 | $9.02K/day | $- | $0.00 | — |